Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription 30.01.2012 1 AJR Am J Roentgenol 1 Am J Clin Oncol 2 Am J Pathol 1 Ann Thorac Surg 2 BMC Cancer 1 Cancer Chemother Pharmacol 2 Cancer Sci 5 Clin Cancer Res 4 Clin Lung Cancer 2 Clin Nucl Med 2 Eur Respir J 4 Int J Oncol 1 J Cancer Res Clin Oncol 2 J Clin Oncol 2 J Natl Cancer Inst 1 Lancet Oncol 4 Lung Cancer 1 Oncogene 1 PLoS One 3 Thorax

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. WAGNETZ U , Menezes RJ, Boerner S, Paul NS, et al
   CT Screening for Lung Cancer: Implication of Lung Biopsy Recommendations.
   AJR Am J Roentgenol. 2012;198:351-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Am J Clin Oncol

2. YOSHIMURA N , Kimura T, Mitsuoka S, Kyoh S, et al
   Dose Escalation and Feasibility Study of Amrubicin Combined With Cisplatin in Previously Untreated Patients With Advanced Non-small-cell Lung Cancer.
   Am J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Am J Pathol

3. BOURBOULIA D , Jensen-Taubman S, Rittler MR, Han HY, et al
   Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.
   Am J Pathol. 2011;179:2589-600.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. WU L , Du H, Li Y, Qu P, et al
   Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.
   Am J Pathol. 2011;179:2131-41.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Ann Thorac Surg

5. HOOKER CM , Meguid RA, Hulbert A, Taylor JT, et al
   Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
   Ann Thorac Surg. 2012;93:405-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Cancer

6. SANZ-SANTOS J , Serra P, Andreo F, Llatjos M, et al
   Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer.
   BMC Cancer. 2012;12:34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ITO M , Niho S, Nihei K, Yoh K, et al
   Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.
   BMC Cancer. 2012;12:27.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Chemother Pharmacol

8. KOBAYASHI T , Koizumi T, Agatsuma T, Yasuo M, et al
   A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer.
   Cancer Chemother Pharmacol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Sci

9. LIAO CJ , Wu TI, Huang YH, Chang TC, et al
   Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.
   Cancer Sci. 2011 Sep 14. doi: 10.1111/j.1349-7006.2011.02102.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. NAGAI H , Ishihara T, Lee WH, Ohara H, et al
    Asbestos surface provides a niche for oxidative modification.
    Cancer Sci. 2011;102:2118-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Cancer Res

11. TAKAHASHI O , Komaki R, Smith PD, Jurgensmeier JM, et al
    Combined MEK and VEGFR Inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. LEE Y , Shim HS, Park MS, Kim JH, et al
    High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. WALTER K , Holcomb T, Januario T, Du P, et al
    DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non-small Cell Lung Cancer.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. AMBROSE LF , Freedman J, Buetow K, Friend S, et al
    Using patient-initiated study participation in the development of evidence for personalized cancer therapy.
    Clin Cancer Res. 2011;17:6651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BRUNSVIG PF , Kyte JA, Kersten C, Sundstrom S, et al
    Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.
    Clin Cancer Res. 2011;17:6847-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Lung Cancer

16. GRIDELLI C , Brodowicz T, Langer CJ, Peterson P, et al
    Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. TAKATANI H , Nakamura Y, Nagashima S, Soda H, et al
    Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. HOPPE BS , Flampouri S, Henderson RH, Pham D, et al
    Proton Therapy With Concurrent Chemotherapy for Non-small-cell Lung Cancer: Technique and Early Results.
    Clin Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GIROUX LEPRIEUR E , Labrune S, Giraud V, Gendry T, et al
    Delay Between the Initial Symptoms, the Diagnosis and the Onset of Specific Treatment in Elderly Patients With Lung Cancer.
    Clin Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Nucl Med

20. DE MARCO L , Mamede M
    Metabolic Pattern of Glomic Tumor by F-18 FDG PET/CT.
    Clin Nucl Med. 2011;36:1051-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. YANG G , Wang X, Wang Z, Jiang Y, et al
    Tc-99m MDP uptake in a giant pulmonary chondroma.
    Clin Nucl Med. 2011;36:1029-30.
    PubMed     Text format     Related articles   
    
    
    

    
    Eur Respir J

22. SCOCCIANTI C , Vesin A, Martel G, Olivier M, et al
    Prognostic value of TP53, KRAS and EGFR mutations in Non-Small Cell Lung Cancer: EUELC cohort.
    Eur Respir J. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. O'MEARA P , Guenette JA, Raghavan N, Amornputtisathaporn N, et al
    Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD.
    Eur Respir J. 2011;38:728-30.
    PubMed     Text format     Related articles   
    
    
    

    
    Int J Oncol

24. CHEN QY , Jiao DM, Yao QH, Yan J, et al
    Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Int J Oncol. 2012 Jan 17. doi: 10.3892/ijo.2012.1336.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TSUKAMOTO S , Honoki K, Fujii H, Tohma Y, et al
    Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
    Int J Oncol. 2012;40:163-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. THOMPSON R , Meuth M, Woll P, Zhu Y, et al
    Treatment with the Chk1 inhibitor Go6976 enhances cisplatin cytotoxicity in SCLC cells.
    Int J Oncol. 2012;40:194-202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. PIETROWSKA M , Polanska J, Suwinski R, Widel M, et al
    Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Int J Oncol. 2012;40:148-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Cancer Res Clin Oncol

28. SUNDARRAJ S , Kannan S, Thangam R, Gunasekaran P, et al
    Effects of the inhibition of cytosolic phospholipase A(2)alpha in non-small cell lung cancer cells.
    J Cancer Res Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

29. DECKER RH , Lynch TJ
    Unmet Challenges in the Use of Novel Agents in Locally Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   
    
    
    
30. HOANG T , Dahlberg SE, Schiller JH, Mehta MP, et al
    Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non-Small-Cell Lung Cancer: The ECOG 3598 Study.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Natl Cancer Inst

31. HENSCHKE CI
    Re: Inconsistencies in Findings from the Early Lung Cancer Action Project Studies of Lung Cancer Screening.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles   
    
    
    
32. SEIJO LM , Montuenga LM, Zulueta JJ
    Re: Inconsistencies in Findings From the Early Lung Cancer Action Project Studies of Lung Cancer Screening.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles   
    
    
    

    
    Lancet Oncol

33. CIULEANU T , Stelmakh L, Cicenas S, Miliauskas S, et al
    Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
    Lancet Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lung Cancer

34. VANSTEENKISTE J , Glaspy J, Henry D, Ludwig H, et al
    Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. GRIDELLI C , de Marinis F, Di Maio M, Ardizzoni A, et al
    Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SANTONICO M , Lucantoni G, Pennazza G, Capuano R, et al
    In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. XUE X , Sun DF, Sun CC, Liu HP, et al
    Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Oncogene

38. SOS ML , Thomas RK
    Genetic insight and therapeutic targets in squamous-cell lung cancer.
    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    PLoS One

39. JIANG G , Wang Y, Dai S, Liu Y, et al
    P120-Catenin Isoforms 1 and 3 Regulate Proliferation and Cell Cycle of Lung Cancer Cells via beta-Catenin and Kaiso Respectively.
    PLoS One. 2012;7:e30303.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Thorax

40. RINTOUL RC , Slade MG
    Another new tool for the diagnostic bronchoscopist.
    Thorax. 2011;66:1027-8.
    PubMed     Text format     Related articles   
    
    
    
41. VLACHOSTERGIOS PJ , Karamagkiolis S, Karamitsos K
    Pulmonary and cutaneous nodules in an immunocompromised patient.
    Thorax. 2011;66:1103.
    PubMed     Text format     Related articles   
    
    
    
42. TREASURE T , Hillerdal G, Utley M
    LUCADA: a valuable resource but there are questions it cannot answer.
    Thorax. 2011;66:1023-4.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: